Subscribe to our Newsletters !!
How are viruses different from bacteria apex ? O
Industries and scientific fields use conductivity
Insects that are given more attention and reverenc
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
Approximately two million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied each week from the middle of January in the United Kingdom, The Times reported.
AstraZeneca expects to supply two million doses of the vaccine in total by next week, the paper reported, citing an unnamed member of the Oxford-AstraZeneca team.
“The plan is then to build it up fairly rapidly – from the third week of January we should get to two million a week,” the report added.
The business wasn’t immediately available to respond to a Reuters request for comment.
The report comes after Britain on Wednesday accepted the Oxford-AstraZeneca COVID-19 vaccine, trusting that rapid action will help it stem a record surge of infections driven by a highly infectious form of the virus.
Prime Minister Boris Johnson has ordered 100 million doses for the country as part of an arrangement with the business.
The company had said it aims to provide millions of doses in the first quarter, including that first vaccinations are slated to start this year.
Britain, which has recorded more than 50,000 new daily cases of COVID-19 for the last four days, is dealing with a rapid spread of a far more infectious version of the coronavirus.
As of Friday, the UK has recorded 53,285 new COVID-19 cases and 613 deaths.
